Author:
Pinder Mary C.,Buzdar Aman U.
Reference44 articles.
1. Baum M, Buzdar A, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Cancer 2003;98:1802–1810.
2. Bertelli G, Garrone O, Merlano M, et al. Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer. Oncology 2005;69:471–477.
3. Bezwoda WR, Gudgeon A, Falkson G, et al. Fadrozole versus megestrol acetate: a double-blind randomised trial in advanced breast cancer. Oncology 1998;55:416–420.
4. Bianco AR, Costanzo R, Di Lorenzo G, et al. The Mam-1 GOCSI trial: a randomised trial with factorial design of chemo-endocrine adjuvant treatment in node-positive (N+) early breast cancer (EBC). Proc Am Soc Clin Oncol 2001;21:27a. Abstract 104.
5. Bonneterre J, Thurlimann B, Robertson JFR, et al. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study. J Clin Oncol 2000;18:3748–3757.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献